ment (SEM) and 1 /2 standard deviation ( 1 /2SD)) and anchor methods against the smallest change on the global rating of change. Missing data were imputed using last observation carried forward. RESULTS: Internal consistency (a = 0.940) and construct validity (SF-36 Role Function r = -0.66; Vitality r = 0.62, Social Function r = 0.71, Pain r = 0.64, SNOT-16 r = 0.67 all P < 0.001) were confirmed with strong correlations. The AIA was sensitive (ES = 0.90; SRM = 0.82). The MID estimated by the anchor method was 2.63; but MID was lower by distributional estimates (SEM = 1.39, 1 /2SD = 2.84). CONCLUSIONS:
Institute, Pune, India, 9 Assistance Publique-Hopitaux de Paris, Paris, France OBJECTIVES: Most Heath-Related Quality of Life (HRQL) questionnaires specific to HIV/AIDS were developed when HIV was a deadly disease. They do not adequately measure the impact of the disease and its treatment on People Living With HIV/AIDS (PLWA) anymore. Relevant domains are missing such as perception about treatment, impact of side effects, lipodystrophy and sleep. Psycho-social impact, especially stigma, is under-evaluated. The objective is to develop a new Patient-Reported Outcomes (PRO) questionnaire to measure the HRQL of PLWA in different countries using an item bank developed with patients. METHODS: The conceptual framework was identified on the basis of patients' interviews. To capture the cultural differences in patients' perceptions, the interviews were held in the five continents: Africa (Senegal), America (Brazil, USA), Australia, Asia (Thailand, China, Cambodia, India) and Europe (France). All interviews were recorded, transcribed and translated into English or French. Important verbatim were selected, transformed into items and organized into a questionnaire developed in French and in English. ). All interviews were recorded, transcribed and translated into English or French. Important verbatim were selected, transformed into items and organized into a questionnaire developed in French and in English. RESULTS: A total of 148 patients were interviewed (47% women), and PRO concepts important to the patients were identified. An endpoint model was designed to explain the relations between PROs: health status, symptoms, side effects and HRQL domains. Cultural differences were identified in daily activities, stigma and relations with family and friends. 300 items were generated in French and in English and organized into a 24-domain item bank. Item reduction to a 70-item questionnaire was done with experts. Full linguistic validation process was performed. CON-CLUSIONS: A new PRO questionnaire specific to HIV was developed. The international development from an early step will enable a better cultural relevance and has improved the translatability of the source questionnaires (French and English) into the target languages. The international psychometric validation study with 900 patients is ongoing.
INFECTION-Health Care Use & Policy Studies PIN50 A REVIEW OF THE FACTORS AFFECTING PUBLIC FUNDING OF VACCINES
De Abreu Lourenco R, Strizek A Covance, North Ryde, New South Wales, Australia OBJECTIVES: To develop an understanding of the adoption decision process for vaccines, and the role of value demonstration (cost-effectiveness) in that process. METHODS: The literature was searched for a) general information on decision criteria applicable to vaccines; b) information specific to vaccine value demonstration; and c) cost-effectiveness analyses for HPV, pneumococcal disease, and dTpa as examples of vaccines recently adopted. Information was extracted by two reviewers to outline a) the general factors affecting vaccine adoption, and b) the role of value demonstration, and (c) what influences vaccine value demonstration. RESULTS: Four published guidelines were identified which outline factors to consider in the vaccine adoption process. These were combined to produce the following framework: 1) The disease: is it a high priority, and an important public health issue? 2) The vaccine: is it safe and effective in reducing disease incidence? 3) The value: is it cost-effective? 4) The socio-political climate: what are the concerns of the major stakeholders and how can they be addressed? and 5) The feasibility: are there sufficient resources to adopt the vaccine? Factors identified as important in determining vaccine cost-effectiveness were: Vaccine efficacy-the more effective, including herd immunity effects, the higher the perceived value; Disease incidence-the higher the incidence, the greater the potential benefit and therefore value; Disease sequalae-the more severe and frequent the sequalae, the higher the potential value in avoiding the condition; and Duration of immunity-the longer the duration, the higher the value as fewer boosters are required. CONCLUSIONS: While we were able to synthesise a framework to describe the vaccine adoption process, no information was found in the literature on how the elements of that framework might be combined, ranked or weighted to reach a decision. Further research into the relative weighting of these factors is warranted.
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EVALUATION OF SEPSIS MANAGEMENT AND OUTCOMES AT A LARGE INNER-CITY ACADEMIC MEDICAL CENTER IN THE SURVIVING SEPSIS CAMPAIGN ERA
Ohuabunwo CJ 1 , Fotzeu C 1 , Heisler M 2 ,VanDenBerg C 3 1 Morehouse School of Medicine, Atlanta, GA, USA, 2 Emory UNiversity, Atlanta, GA, USA, 3 Grady Health System, Atlanta, GA, USA OBJECTIVES: Assess the severe sepsis diagnosis and management practices based on the SSC guidelines and quality indicators. Determine the case severity level and outcomes of severe sepsis in an inner city hospital setting. Ascertain the average direct cost of severe sepsis hospitalization in this setting. METHODS: Using an explanatory cross-sectional evaluation design, demographic, administrative, clinical and laboratory data of all patients with physician-diagnosed sepsis admitted during March-May 2007 were reviewed. The SSC-IHI severe sepsis screening/chart measurement tools and quality indicators were used for data collection and performance assessment respectively. Process measures were; time-to-blood culture, blood culture-antibiotic sequence, time-toantibiotic, CVP goal, CV Oxygen saturation goal, Low-dose A444 Abstracts
